Transcatheter aortic valve implantation: What has been done and what is going to be done

Future Cardiology

Volumn 6, Issue 1, 2010, Pages 83-95

  Tamburino, Corrado ^a,b   Barbanti, Marco ^a   Capodanno, Davide ^a,b   Ussia, Gian Paolo ^a,b  

^a UNIVERSITY OF CATANIA   (Italy)

^b ETNA Foundation   (Italy)

Author keywords

Aortic stenosis; New technologies; Percutaneous; Prosthesis

Indexed keywords

HEPARIN; NITINOL;

AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BALLOON DILATATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; FALSE ANEURYSM; GENERAL ANESTHESIA; HEART VALVE BIOPROSTHESIS; HUMAN; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHESIS FIXATION; REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TRANSLUMINAL VALVULOPLASTY; VASCULAR ACCESS DEVICE;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS;

EID: 73949153221     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.09.53     Document Type: Review

References (48)

1. Nkomo VT, Gardin JM, Skelton TN et al.: Burden of valvular heart diseases: a population-based study. Lancet 368, 1005-1011 (2006).
2. Iung B, Baron G, Butchart EG et al.: A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular disease. Eur. Heart J. 24, 1231-1243 (2003).
3. Varadarajan P, Kapoor N, Bansal RC, Pai RG: Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann. Thorac. Surg. 82, 2111-2115 (2006).
4. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography Interventions, Society of Thoracic Surgeons; Bonow RO, Carabello BA, Kanu C et al.: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114, E84-E231 (2006).
5. Vahanian A, Baumgartner H, Bax J et al.: Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230-268 (2007).
6. Kolh P, Kerzmann A, Honore C, Comte L, Limet R: Aortic valve surgery in octogenarians: predictive factors for operative and long term results. Eur. J. Cardiothorac. Surg. 31, 600-606 (2007).
7. Melby SJ, Zierer A, Kaiser YP et al.: Aortic valve replacement in octogenarians. Risk factors for early and late mortality. Ann. Thorac. Surg. 83, 1651-1657 (2007).
8. Craver JM, Puskas JD, Weintraubb WW et al.: 601 octogenarians undergoing cardiac surgery: outcome and comparison with younger age groups. Ann. Thorac. Surg. 67(4), 1104-1110 (1999).
9. Kolh P, Kerzmann A, Lahaye L, Gerard P, Limet R: Cardiac surgery in octogenarians: peri-operative outcomes and long term results. Eur. Heart J. 22, 1235-1243 (2001).
10. Shapira OM, Kelleher RM, Zelingher J et al.: Prognosis and quality of life after valve surgery in patients older than 75 years. Chest 112, 885-894 (1997).
11. Scott BH, Seifert FC, Grimson R, Glass P: Octogenarians undergoing coronary artery bypass graft surgery; resource utilization, postoperative mortality and morbidity. J. Cardiovasc. Vasc. Anesth. 19, 583-588 (2005).
12. Andersen HR, Knudsen LL, Hasenkam JM: Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur. Heart J. 13, 704-708 (1992).
13. Cribier A, Eltchaninoff H, Bash A et al.: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006-3008 (2002).
14. Piazza N, de Jaegere P, Schultz C et al.: Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ. Cardiovasc. Intervent. 1, 74-81 (2008).
15. Roques F, Nashef SA, Michel P; EuroSCORE study group: Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J. Heart Valve Dis. 10, 572-577 (2001).
16. Shroyer AL, Coombs LP, Peterson E et al.; the Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann. Thorac. Surg. 75, 1856-1865 (2003).
17. Dewey TM, Brown D, Ryan WH et al.: Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J. Thorac. Cardiovasc. Surg. 135, 180-187 (2008).
18. Grossi EA, Schwartz CF, Yu PJ et al.: High-risk aortic valve replacement: are the outcomes as bad as predicted? Ann. Thorac. Surg. 85, 102-106 (2008).
19. Vahanian A, Alfieri O, Al-Attar N et al.: Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of CardioThoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 11, 1463-1470 (2008).
20. Grube E, Laborde JC, Zickmann B et al.: First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc. Interv. 66, 465-469 (2005).
21. Grube E, Laborde JC, Gerckens U et al.: Percutaneous implantation of the CoreValve® self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 114, 1616-1624 (2006).
22. Grube E, Schuler G, Buellesfeld L et al.: Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current thirdgeneration self-expanding CoreValve® prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69-76 (2007).
23. Piazza N, Grube E, Gerckens U et al.; on the behalf of the clinical centres who actively participated in the registry: Procedural and 30-day outcomes following transcatheter aortic\valve implantation using the third generation (18 Fr) CoreValve® ReValving System: results from the multicentre, expanded\evaluation registry 1-year following CE mark approval. EuroInterv. 4, 242-249 (2008).
24. Grube E, Buellesfeld L, Mueller R et al.: Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve® revalving system. Circ. Cardiovasc. Intervent. 1, 167-175 (2008).
25. Tamburino C, Capodanno D, Mulè M et al.: Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current thirdgeneration self-expanding CoreValve® prosthesis. J. Invasive Cardiol. 21, 93-98 (2009).
26. Laborde JC: Access and closure issues: The subclavian/trans-axillary approach. Presented at: Transcatheter Valve Therapies Workshop 2009. Seattle, WA, USA, 25-26 June 2009.
27. Bleiziffer S, Ruge H, Mazzitelli D et al.: Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur. J. Cardiothorac. Surg. 35, 615-620 (2009).
28. Shuler G: CoreValve ReValving® Experience Post-CE Mark Results of Percutaneous Aortic Valve Replacement (PAVR) Procedures through 30-April-2009 with Data Collected through 12 May 2009. Presented at: Transcatheter Cardiovascular Therapeutics Congress. San Francisco, CA, USA, 21 September 2009.
29. Piazza N, Onuma Y, Jesserun E et al.: Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. JACC Cardiovasc. Interv. 1, 310-316 (2008).
30. Calvi V, Puzzangara E, Pruiti GP et al.: Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin. Electrophysiol. 32, S126-S130 (2009).
31. Ussia GP, Mulè M, Barbanti M et al.: Quality of life assessment after percutaneous aortic valve implantation. Eur. Heart J. 30, 1790-1796 (2009).
32. Cribier A, Eltchaninoff H, Tron C et al.: Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47, 1214-1223 (2006).
33. Webb JG, Chandavimol M, Thompson CR et al.: Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842-850 (2006).
34. Webb JG, Pasupati S, Humphries K et al.: Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116, 755-763 (2007).
35. Webb JG, Altwegg L, Masson JB et al.: A new transcatheter aortic valve and percutaneous valve delivery system. J. Am. Coll. Cardiol. 53, 1855-1858 (2009).
36. Webb JG, Altwegg L, Boone RH et al.: Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119, 3009-3016 (2009).
37. Ye J, Cheung A, Lichtenstein SV et al.: Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients. J. Thorac. Cardiovasc. Surg. 137, 167-173 (2009).
38. Ussia GP, Barbanti M, Mangiafico S et al.: Paravalvular leak reduction after transcatheter aortic valve replacement with self-expandable biological prosthesis. J. Am. Coll. Cardiol. 53, A410-A411 (2009).
39. Ussia GP, Mulè M, Tamburino C: The valve-in-valve technique: transcatheter treatment of aortic bioprosthesis mal position. Catheter Cardiovasc. Interv. 73, 713-716 (2009).
40. Piazza N, Schultz C, de Jaegere P, Serruys PW: Implantation of two selfexpanding aortic bioprosthesis valves during the same procedure? Insight into valve-invalve implantation ('Russian Doll' concept). Catheter Cardiovasc. Interv. 73, 530-553 (2009).
41. Sinhal A, Altwegg L, Pasupati S et al.: Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc. Interv. 1, 305-309 (2008).
42. Buellesfeld L, Gerckens U, Grube E: Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter Cardiovasc. Interv. 71, 579-584 (2008).
43. Low RI, Bolling SF, Yeo KK, Ebner A: Direct flow percutaneous aortic valve: proof of concept. EuroInterv. 4, 256-261 (2008).
44. Schofer J, Schlüter M, Treede H et al.: Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ. Cardiovasc. Intervent. 1, 126-133 (2008).
45. Cannon LA: 'AorTx: The Low Profile Self-expanding Valve'. Presented at: Transcatheter Cardiovascular Therapeutics Congress. Washington DC, ML, USA, 13 October 2008.
46. Figullas HR: The Jena Valve Aortic Leaflet Clip Concept. Presented at: Transcatheter Cardiovascular Therapeutics Congress. San Francisco, CA, USA, 25 September 2009.]
47. Lauten A, Ferrari M, Petri A et al.: Experimental evaluation of the JenaClip transcatheter aortic valve. Circ. Cardiovasc. Intervent. 74, 514-519 (2009).
48. Falk V, Schwammenthal EE, Kempfert J et al.: New anatomically oriented transapical aortic valve implantation. Ann. Thorac. Surg. 87, 925-926 (2009).